AdvaMed Publish Date: November 3, 2022 Read the Full Article>> Challenges of AI in MedTech In the medical device space, powerful insights from real-world data can seem ‘just out of reach’. Capturing patient characteristics and outcomes, at scale and with consistency over time, is challenging outside of clinical trials. Personalization – bridging the gap between[…]
Tue, Oct 18, 2022 11:00 AM – 12:00 PM EDT Presenter: Joseph Zabinski, Senior Director, AI & Precision Medicine, OM1 Register >> As population health moves towards personalized, precision medicine, optimizing treatment options and reducing ineffective care will be critical to plans’ success and differentiation in highly competitive environments. Real-world evidence drawn from deep datasets[…]
Sage Journals Published June 22, 2022 Read the Full Manuscript>> Abstract Background Disability assessment using the Expanded Disability Status Scale (EDSS) is important to inform treatment decisions and monitor the progression of multiple sclerosis. Yet, EDSS scores are documented infrequently in electronic medical records. Objective To validate a machine learning model to estimate EDSS scores[…]
Real-World Evidence Alliance Online Read the Full Article>> Washington, D.C. (April 5, 2022) – The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE). The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics organizations with[…]
Wed, Aug 18, 2021 2:00 PM – 3:00 PM EDT Presenter: Richard Gliklich, MD, CEO, OM1 Register >> Automated, clinical ‘data networks’ are transforming the research paradigm. This webinar explores: – How do multi-purpose, ‘reusable’ data networks differ from the traditional research model, in particular for real-world evidence and patient registries? – How are data[…]
